Targeting Phospho-Ser422 by Active Tau Immunotherapy in the THYTau22 Mouse Model: A Suitable Therapeutic Approach

Publisher： Bentham Science Publishers

E-ISSN： 1875-5828|9|4|397-405

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.9, Iss.4, 2012-05, pp. : 397-405

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Loss of Medial Septum Cholinergic Neurons in THY-Tau22 Mouse Model: What Links with tau Pathology?

By  

Current Alzheimer Research, Vol. 8, Iss. 6, 2011-09 ,pp. : 633-638

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of Small Molecule Inhibitors of Tau Aggregation by Targeting Monomeric Tau As a Potential Therapeutic Approach for Tauopathies

By  

Current Alzheimer Research, Vol. 12, Iss. 9, 2015-11 ,pp. : 814-828

Bentham Science Publishers

Access to resources Recommend Favorite

Immunotherapy for Targeting Tau Pathology in Alzheimer’s Disease and Tauopathies

By  

Current Alzheimer Research, Vol. 10, Iss. 3, 2013-03 ,pp. : 217-228

Bentham Science Publishers

Access to resources Recommend Favorite

CSF phospho-tau correlates with behavioural decline and brain insoluble phospho-tau levels in a rat model of tauopathy

By Zilka Norbert   Korenova Miroslava   Kovacech Branislav   Iqbal Khalid   Novak Michal  

Acta Neuropathologica, Vol. 119, Iss. 6, 2010-06 ,pp. : 679-687

Springer Publishing Company

Access to resources Recommend Favorite

Disaggregation of Tau as a Therapeutic Approach to Tauopathies

By  

Current Alzheimer Research, Vol. 7, Iss. 3, 2010-05 ,pp. : 235-240

Bentham Science Publishers

Access to resources Recommend Favorite